Non‐Alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and is
characterized by fat accumulation in the liver. Hypercaloric diets generally increase hepatic …

Nonalcoholic fatty liver disease (NAFLD) includes hepatic steatosis, nonalcoholic
steatohepatitis (NASH), fibrosis, and cirrhosis. NAFLD is the most common liver disorder in …

Nonalcoholic fatty liver disease (NAFLD) is characterized by the development of steatosis,
which can ultimately compromise liver function. Mitochondria are key players in obesity …

The worldwide epidemic of obesity and insulin resistance favors nonalcoholic fatty liver
disease (NAFLD). Insulin resistance (IR) in the adipose tissue increases lipolysis and the …

Nonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the
United States and includes a spectrum of disease that includes simple steatosis, non …

Nonalcoholic fatty liver disease (NAFLD) is a dysmetabolic hepatic damage of increasing
severity: simple fat accumulation (steatosis), nonalcoholic steatohepatitis (NASH), and …

Non-alcoholic fatty liver disease (NAFLD) is a growing epidemic, in parallel with the obesity
crisis, rapidly becoming one of the commonest causes of chronic liver disease worldwide …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly reported pathology,
characterized by fat accumulation within the hepatocyte. Growing evidences suggest …

Objective Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and is associated with an enhanced risk for liver and cardiovascular diseases and …

NAFLD (non-alcoholic fatty liver disease), associated with obesity and the cardiometabolic
syndrome, is an important medical problem affecting up to 20% of western populations …